Neutropenia as A Probable Side Effect of Regular Insulin Therapy-A Case Report
Abbas M Abbas1, Walid G Babikr2, Aarif Alhassan3, Nafaa Alnafaa4, Abdullah I. Aedh2 and Hamdan Alshehri21Endocrinologist, Domat Al-gendal Hospital, Aljouf-Saudi Arabia.
2Assistant Professor of Internal Medicine, Faculty of medicine, Najran University, Saudi Arabia.
3Cosultant Physician, the diabetes center, Al-jouf, Saudi Arabia.
4Medical Specialist, Domat Al-gendal Hospital, Aljouf-Saudi Arabia.
Corresponding author E-mail: walidbabikr@yahoo.comom
Abstract: Neutropenia or [agranulocytosis] means reduced number of circulating neutrophils. It is commonly defined as an absolute neutrophil count [ANC]more than two standard deviations below the normal mean.1 Neutropenia may be classified as mild (1.0 to 1.5 × 109/L), moderate (0.5 to 1.0 × 109/L), or severe (<0.2 × 109/L), 2 the later can markedly increase susceptibility to devastating bacterial infections and a significant increase in mortality risk.3 The association between neutropenia and medical drug use has been recognized since earlier in the twentieth century by American investigators.4 Drug-induced hematological disorders can span almost the entire spectrum of hematology, affecting red cells, white cells, platelets, and the coagulation system.
Keywords: Anticonvulsants; Antihistaminics; Antirheumatics; Neutropenia Back to TOC